ETFMG Alternative Harvest ETF
Latest ETFMG Alternative Harvest ETF News and Updates
Gauging the Bullish-Bearish Sentiment on Aphria
The short interest position on a stock is one quick way to gauge the bullish and bearish sentiment on a stock.
Analysts’ Estimates for Canopy Growth’s Earnings
Canopy Growth (WEED) (CGC) is expected to report a loss per share of ~0.15 Canadian dollars.
Here’s What Jim Cramer Had to Say about the Cronos-Altria Deal
Jim Cramer said Altria’s acquisition of a 45% stake in Cronos Group last week was a “smart move” for Altria.
Cronos Group Invests in the Future
Through Cronos Group’s partnership with Ginko Bioworks, the company aims to produce cannabis through fermentation.
Aurora Cannabis: Analysts’ Projections
Analysts expect Aurora Cannabis to report a gross income of 177 million Canadian dollars in 2019 and 508 million Canadian dollars in 2020.
Does Cronos Group Look Expensive Compared to Its Peers?
Cronos Group (CRON) has been on a declining trend for a while. The stock rose to a peak of ~30 Canadian dollars in February.
Why Aurora Cannabis Calls Itself a ‘Medical Company at Heart’
Aurora Cannabis (ACB) reported its Q2 earnings yesterday, which gave us a glimpse of recreational cannabis sales activity and what to expect from peers’ (MJ) upcoming earnings.
Top Developments in the Cannabis Industry’s Early Years
In the second half of 2018, the cannabis industry remained busy. As the cannabis sector experienced a boom, there was a lot of excitement among investors.
Cannabis Legalization: Four Governors Met in New York
The Day reported that New York, New Jersey, Connecticut, and Pennsylvania’s governors met and agreed on basic guidelines for legalizing marijuana.
Comparing the Valuation Multiples of Cannabis Stocks
In this part of our cannabis valuation series, we’ll discuss the multiples of the remaining cannabis stocks and compare them to the peer (MJ) median of 24x.
iAnthus to Open Three Dispensaries in Florida by End of 2018
Today, iAnthus Capital Holdings (ITHUF) announced it will open its first dispensary in Florida on December 19.
Gundlach Compares Cannabis to Bitcoin
Jeffrey Gundlach predicted bitcoin’s (BTC) crash after the cryptocurrency’s peak in December 2017.
Big News: Cannabis Edibles in Alberta Stores
Many people expected the Cannabis 2.0 products, including cannabis edibles, to hit the markets by mid-December 2019. However, the products got delayed.
Kamala Harris: Presidential Candidate for Legalizing Marijuana
Senator Kamala Harris, who also announced her 2020 presidential bid, supports legalizing marijuana at a federal level.
Cannabis Stocks Continue to Struggle on the Last Day of April
The cannabis sector has continued to struggle on the last day of April, and it may very well end up in negative territory.
Cannabis Roundup: HEXO, WEED, ACB, and CTST
The broader US markets were relatively flat today. Weakness in the cannabis sector continued, with the ETFMG Alternative Harvest ETF down 0.4%.
What Analysts Estimate for Cannabis Companies’ Earnings Margins
Let’s now look at how capacity expansion could translate into cannabis companies’ margins.
Cannabis Sector: A Week in Review for Sept 20
Last week, the overall cannabis sector remained subdued. Sector ETFs, such as the Horizons Marijuana Life Sciences ETF (HMMJ), closed about 8.15% lower.
Why Canopy Growth Is a ‘Buy’ before Its Earnings
Despite the surge in May, Canopy Growth is still trading at a 54.3% discount from its 52-week high of $59.74. So, should you buy the stock?
Curaleaf Opens Medical Marijuana Dispensary in Tallahassee
On November 16, Curaleaf Holdings announced that the company opened Tallahassee’s largest medical marijuana dispensary.
Cannabis Stocks Up, Broader Equity Market Falls
Today, cannabis stocks are trading in the green despite the weakness in the broader market. The ETFMG Alternative Harvest ETF was up 2.5% as of 2:00 PM ET.
How Analysts View Cresco Labs before Its Q1 Release
Cresco Labs (CRLBF) is slated to release its first-quarter earnings on May 29.
CGC: How the Future Looks Under Its New CEO
On December 9, Canopy Growth (CGC) appointed David Klein as its new CEO effective January 14. He’s the current CFO of Constellation Brands.
Cannabis Stocks Had a Mixed Performance Last Week
Cannabis ETFs traded on a largely negative note last week.
IIPR Stock Moves Higher after New Debt Is Raised
Last week, Innovative Industrial Properties (IIPR) offered $125 million in senior notes, giving initial investors the option to exercise $18.75 million in additional principal amount notes.
Aurora Cannabis Releases Update on Cannabis 2.0
Aurora Cannabis (ACB) is going through a rough patch. This year, the company’s stock has lost 60.9% of its value as of December 23.
Cannabis Stocks: What Happens in a Recession?
As market analysts increasingly predict an upcoming global recession, we take a look at the impact of a recession on cannabis stocks.
What’s the Market Potential for CBD?
The FDA has issued warning letters to 15 companies involved in illegal sales of non-psychoactive CBD products. What’s the legal market’s potential?
Considerations for Investors in Marijuana or Cryptocurrencies
The forecasting of future cash flows depends on the market potential for legalized medical and recreational marijuana.
Will Mexico Legalize Cannabis by the End of the Month?
With more countries now warming up to cannabis, let’s look at how Mexico is shaping up in terms of cannabis legalization.
One Chart That Shows What Makes Cannabis Attractive to Altria
As the cannabis space has increasingly become crowded, companies such as Cronos Group would greatly benefit from a company such as Altria.
Cannabis Investing in 2019: A Year of Big Reversals
The cannabis sector has seen a bit of a Jekyll and Hyde situation in 2019. In the first half, cannabis ETFs rose, but in the second half, they plummeted.
Why Origin House’s Acquisition Is Vital for Cresco Labs
On December 31, 2019, Origin House (OH) announced that its shareholders had approved Cresco Labs’ (CRLBF) acquisition plan.
Comparing GW Pharmaceuticals’ Returns to Peers
GW Pharmaceuticals has received a “strong buy” rating from four analysts, while eight have rated it as a “buy” or some equivalent.
OrganiGram Receives Expansion License from Health Canada
On Monday, OrganiGram Holdings (NASDAQ:OGI) announced that it received a license from Health Canada to expand its Phase 5.
Comparing Cannabis Stocks’ Valuation Multiples in November
Aurora Cannabis (ACB) was trading at a multiple of 26.4x, which declined from 34x in October.
Can Canopy Growth’s Q3 Earnings Lift the Cannabis Sector?
On Friday, Canopy Growth will report its third-quarter earnings before the market opens. Investors will be watching the results closely.
OrganiGram Stock Falls after Disappointing Q3 Earnings
Today, OrganiGram Holdings (NASDAQ:OGI) reported its third-quarter earnings. As expected, the results were disappointing.
Aurora Cannabis Appoints New Chief Commercial Officer
As the demand for Cannabis 2.0 products continues to rise, Aurora Cannabis announced the appointment of Miguel Martin as its new chief commercial officer.
Curaleaf Holdings Completes Curaleaf NJ’s Acquisition
Curaleaf Holdings (OTCMKTS:CURLF) continued its expansion by completing the acquisition of Curaleaf NJ, which owns a medical license in New Jersey.
HEXO Enters Israel’s Medical Marijuana Market, Stock Surges over 18%
Today, HEXO announced that it launched its medical marijuana products in Israel. The company signed a two-year agreement with an Israeli cannabis company.
Is Aphria or OrganiGram a Better Buy for Investors?
Analysts expect Aphria to report revenues of $631.8 million in the next four quarters. Management will focus on the medical and recreational sectors.
What to Expect from OrganiGram’s Q3 Earnings
OrganiGram will likely report its third-quarter earnings before the market opens on July 21. Overall, there isn’t much hope.
Aphria Stock Rose More than 8% after Stifel’s Upgrade
Aphria (NYSE:APHA) received a bullish call from Stifel. On Monday, Stifel upgraded the stock from a “hold” to a “buy” rating.
Curaleaf Plans a Nationwide Expansion of ‘Select’ Brand
Curaleaf (OTCMKTS:CURLF) acquired a “Select” brand in February 2020. The company received positive feedback in medical and adult-use markets.
Why Did Raymond James Downgrade OrganiGram?
On Monday, Cantech Letter reported that Raymond James downgraded OrganiGram from an “outperform” rating to a “market perform” rating.
Green Thumb Keeps Expanding Its Operations in Las Vegas
On June 27, Green Thumb Industries (OTCMKTS:GTBIF) opened its fifth Essence brand store in Las Vegas and its 48th retail store in the US.
Canopy Growth Announces Initiatives to Regain Market Share
In the fourth quarter, Canopy Growth (NYSE:CGC)(TSE:WEED) lost market share due to increased competition in value products.
Why Canadian Cannabis Sales Dipped Slightly in April
In April, cannabis sales came in at $180.1 million—0.6% down from the March sales. So, considering the spike in March, the sales weren’t disappointing.
MedMen’s Medical Marijuana Dispensary License Revoked in Virginia
The Virginia Board of Pharmacy voted not to extend MedMen’s conditional license to operate a medical marijuana dispensary in Staunton, Virginia.
Tilray Rebounded in Q1, Most Analysts Recommend a ‘Hold’
Tilray hasn’t reported a positive EBITDA yet. Analysts expect the company to become profitable in the first quarter of 2021.
Canopy Growth CEO Expects US to Legalize Cannabis by 2022
Amid the growing support for cannabis legalization, Canopy Growth (NYSE:CGC) CEO David Klein expects the federal government to legalize marijuana by 2022.
Top 2 Cannabis Stocks to Buy, Interest in the Sector Reignites
After underperforming the broader equity markets in the first quarter, the cannabis sector has been showing a strong recovery in the second quarter.
Curaleaf Expands Select Brand Medical Products in Connecticut
On Monday, Curaleaf Holdings announced that it will expand its Select brand products in Connecticut. The products will be available at medical dispensaries.
Canada’s Cannabis Oil Exports Rose More than 450% in 2019
Canada, with first-mover advantage, has been exploring new territories to export its cannabis oil. Last year, the company reported to 17 counties.
IIPR Acquires Another Property in Pennsylvania
Innovative Industrial Properties has continued its aggressive expansion. IIPR acquired a new property in Pennsylvania from Holistic Industries.
Illinois Reports Record Recreational Cannabis Sales in May
Illinois sold recreational cannabis worth $44.3 million in May—the highest amount since it legalized recreational sales in January this year.
Vireo Health Terminates Bruce Linton as Its Executive Chairman
On Monday, Vireo Health announced that it terminated Bruce Linton as its executive chairman immediately. He joined the company in November 2019.
Why California’s Legal Cannabis Sales Could Fall This Year
The budget proposed by Governor Gavin Newsom projected a decline in California’s cannabis sales. COVID-19 induced a recession in the US economy.
Closing Facility Could Cost Tilray $28 Million in Non-Cash Charges
On May 26, Tilray (NASDAQ:TLRY) announced that it will permanently shut down its High Park Gardens facility located in Leamington, Ontario.
Why Are Canadian Cannabis Companies Leaving Jamaica?
Canadian cannabis companies are frustrated by the Jamaican government’s inaction. They have decided to cut their losses and exit the Jamaican market.
Curaleaf: Analysts’ Recommendations after Its Q1 Earnings
Earlier this week, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings. The company missed analysts’ revenue expectations.
Aurora Cannabis to Enter US CBD Market, Stock Rises over 30%
On Wednesday, Aurora Cannabis (NYSE:ACB) announced that it has signed an agreement to acquire Reliva—a US-based CBD company.
Why Did Curaleaf Report a Mixed Q1 Performance?
On Monday, Curaleaf (OTCMKTS:CURLF) reported its first-quarter earnings after the market closed. The company reported revenue of $96.5 million.
Why Curaleaf Is a ‘Buy’ before Its Q1 Earnings
Analysts expect Curaleaf’s EBITDA to rise during the quarter. They expect the company to report an EBITDA of $15.7 million.
Charlotte’s Web Reports Mixed Q1 Performance
Today, Charlotte’s Web reported a mixed first-quarter performance. For the quarter ended on March 31, the company reported revenues of $21.7 million.
GW Pharmaceuticals Stock Rises on Higher Epidiolex Sales
On Monday, GW Pharmaceuticals reported its first-quarter earnings. The company beat analysts’ revenue, EBITDA, and EPS expectations.
Tilray Posts Q1 Results, Stock Falls, and Net Losses Widen
On Monday, Tilray (NASDAQ:TLRY) reported its first-quarter earnings after the market closed. For the quarter, the company posted revenues of $52.1 million.
Why Did Aphria Stock Fall 7% on May 8?
On May 8, Aphria’s (NYSE:APHA) management announced that it agreed to repurchase its convertible senior notes from some holders outside of Canada.
Why Analysts Are Bullish before Charlotte’s Web’s Q1 Earnings
Charlotte’s Web Holdings (OTCMKTS:CWBHF)(NYSEARCA:CWEB) will likely report its first-quarter earnings before the market opens on May 14.
Tilray’s Q1 Earnings Could Boost Its Stock Price
The meltdown in global financial markets amid COVID-19 dragged Tilray stock down to $2.43 on March 18. Since then, the stock has recovered.
IIPR Stock Falls after Reporting Weak Q1 Performance
On May 6, Innovative Industrial Properties reported its first-quarter results after the market closed. The company posted an adjusted EPS of $0.72.
Why Has Aphria Risen in Today’s Pre-Trading Hours?
Today, Aphria (NYSE:APHA) announced that ASG Pharma has received EU GMP certification to produce cannabis for medical and research purposes.
Aphria Looks Attractive in the Cannabis Space
Aphria reported an adjusted EBITDA of $5.7 million in the third quarter. The company has reported a positive EBITDA for four consecutive quarters.
Should You Buy IIPR before Its Q1 Earnings?
IIPR will likely report its first-quarter earnings, which ended on March 31, after the market closes on May 6. So, should you buy the stock?
Why Is There Optimism before Cresco Labs’ Q4 Earnings?
Analysts expect Cresco Labs to report revenue of $43.7 million in the fourth quarter—YoY growth of 157.9% from $17.0 million in the fourth quarter of 2018.
Why Did Canopy Growth Stock Rise on Monday?
Canopy Growth (NYSE:CGC)(TSE:WEED) stock rose to a high of 22.66 Canadian dollars before closing at 21.46 Canadian dollars on Monday.
Canopy Growth to Exit Africa, Close Another Canadian Facility
Canopy Growth announced another set of global operational changes to optimize its production, improve efficiency, and align its supply with the demand.
Why Analysts Had Mixed Reactions to Aphria’s Q3 Earnings
On April 14, Aphria (NYSE:APHA) reported its third-quarter earnings. For the quarter, the company reported revenues of 144.4 million Canadian dollars.
Comparing Canopy Growth and Aurora Cannabis’s Valuation Multiples
Canopy Growth and Aurora Cannabis are two prominent players in the cannabis sector. So far in 2020, Canopy Growth has outperformed cannabis ETFs.
Will Aphria’s Q3 Earnings Lift the Cannabis Sector?
Analysts expect Aphria to report revenue of 130.6 million Canadian dollars in the third quarter—growth of 77.5% YoY and a sequential increase of 8.3%.
OrganiGram to Reduce Workforce by 45% Due to COVID-19
OrganiGram has joined the list of cannabis companies, like Canopy Growth and Aurora Cannabis, that will reduce their workforce.
Bruce Linton: WEED and CRON Can Handle COVID-19 Storm
On April 6, Bruce Linton said that Canopy Growth (TSE:WEED) and Cronos Group (NASDAQ:CRON) are better equipped to withstand the COVID-19 storm.
Comparing OrganiGram and Aphria’s Valuation Multiples
So far this year, OrganiGram Holdings (NASDAQ:OGI) and Aphria (NYSE:APHA) have lost 11.0% and 36.7% of their stock price.
3 Cannabis Stocks Investors Should Watch as Markets Rebound
As the markets start to rebound, three cannabis stocks could deliver strong returns. Cannabis sales have increased amid the coronavirus outbreak.
Curaleaf Reports Impressive Q4 Earnings Results
On Tuesday, Curaleaf (OTCMKTS:CURLF) reported its fourth-quarter earnings after the market closed. The company reported revenue of $75.46 million.
Cannabis Stocks Outperformed Broader Equity Markets Last Week
Last week was the worst week since October 2008. However, the cannabis sector fared better than the broader equity markets.
Why Did Bank of America Upgrade Aphria and OrganiGram?
On March 19, Bank of America upgraded Aphria (NYSE:APHA) and OrganiGram Holdings (NASDAQ:OGI) due to the increased demand for cannabis.
Will Curaleaf Beat Analysts’ Expectations in Q4?
Curaleaf Holdings (OTCMKTS:CURLF) will report its fourth-quarter earnings after the market closes on March 24. Analysts are bullish on Curaleaf.
What to Expect from Charlotte’s Web’s Q4 Earnings
Charlotte’s Web Holdings (NYSEARCA:CWEB) will report its earnings for the fourth quarter of 2019 before the market opens on March 24.
Roth Capital Initiates Coverage on IIPR with a ‘Buy’ Rating
On March 16, Roth Capital initiated coverage on Innovative Industrial Properties (NYSE:IIPR) with a “buy” rating and a stock price of $110.
Will the Fed’s Rate Cut Help Marijuana Stocks?
The marijuana sector saw a sharp decline last week amid the global sell-off. The S&P 500 fell by 8.8% in the week ending on March 13.
Analysts Recommend a ‘Buy’ for Curaleaf before Its Q4 Earnings
As of Thursday, nine analysts covered Curaleaf. Among the analysts, eight recommend a “buy,” while one recommends a “hold.”
Alabama Gets Closer to Legalizing Medical Marijuana
On Thursday, WBRC reported that the Alabama Senate cleared Senate Bill 165. The bill will create the Compassion Act, which legalizes medical marijuana.
IIPR Looks Promising amid Struggling Cannabis Sector
As of March 11, Innovative Industrial Properties (NYSE:IIPR) was trading at $76.96—a rise of 1.4% since the beginning of this year.
Stifel Initiated Its Coverage on Aphria and HEXO
On Tuesday, MarketWatch reported that Stifel initiated its coverage on Aphria and HEXO. Stifel gave Aphria a “hold” and HEXO a “sell” rating.
Canopy Growth Will Close Facilities and Cut Jobs
Yesterday, Canopy Growth (NYSE:CGC)(TSE:WEED) announced that it’s optimizing its operations to align its supply based on demand.
Charlotte’s Web Reports Improved Yield and CBD Potency
On Wednesday, Charlotte’s Web Holdings (NYSEARCA:CWEB) announced that the audit of its 2019 hemp harvest is complete.
How Will Curaleaf Benefit from Acquiring BlueKudu?
On Monday, Curaleaf (OTCMKTS:CURLF) announced that it will acquire BlueKudu—a company that produces premium cannabis chocolates and gummies.
Should You Consider Buying Canopy Growth?
As of February 28, Canopy Growth (NYSE:CGC)(TSE:WEED) was trading at 25.17 Canadian dollars. So far, the company has lost 7.8% of its stock value YTD.